Retinol binding protein determination reagent kit (latex immunoturbidimetric assay) - NMPA Registration 冀械注准20142400288
Access comprehensive regulatory information for Retinol binding protein determination reagent kit (latex immunoturbidimetric assay) in the China medical device market through Pure Global AI's free database. This Class II medical device is registered under NMPA registration number 冀械注准20142400288 and owned by Langfang Hengyi Biotechnology Co., Ltd.. The device was approved on November 07, 2019.
This page provides complete registration details including registrant information, province location (Hebei), intended use, and regulatory compliance data from the official China NMPA medical device database. Pure Global AI offers free access to China's complete medical device registry, helping global MedTech companies navigate NMPA regulations efficiently.
It is used for the quantitative determination of retinol-binding protein (RBP) content in human serum or urine in vitro.
用于体外定量测定人血清或尿液中视黄醇结合蛋白（RBP）的含量。
Reagent 1: phosphate buffer, 40 mmol/L; Polyethylene glycol 6000, 83mmol/L. Reagent 2: phosphate buffer, 40 mmol/L; Sheep anti-human RBP antiserum, ≥ 50mg/L.
试剂1：磷酸盐缓冲液，40mmol/L；聚乙二醇6000，83mmol/L。试剂2：磷酸盐缓冲液，40mmol/L；羊抗人RBP抗血清，≥50mg/L。